NCCN RADIATION TREATMNET GUIDELINES

Radiation therapy, either alone or in combination with chemotherapy or surgery, is one of the most common treatment options for people with cancer. Nearly two-thirds of patients with cancer in the United States receive radiation therapy during their illness.

To support clinical decision-making around the use of radiation therapy in patients with cancer, the National Comprehensive Cancer Network® (NCCN®) launched the NCCN Radiation Therapy Compendium™ during the NCCN 22nd Annual Conference in Orlando, Florida. The radiation therapy recommendations contained in the Compendium are derived directly from the library of NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), which document evidence-based, consensus-driven management to ensure that all patients receive care most likely to lead to optimal outcomes.

“NCCN is proud to introduce the NCCN Radiation Therapy Compendium™—the latest addition to the library of NCCN Guidelines derivative resources,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “As a single source for all radiation therapy recommendations within the NCCN Guidelines, the Compendium benefits patients with cancer by assisting providers and payers in making evidence-based treatment and coverage decisions.”

The Compendium provides guidance on all radiation therapy modalities recommended within the NCCN Guidelines, including intensity-modulated radiation therapy, intra-operative radiation therapy, stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy, image-guided radiotherapy, low dose-rate brachytherapy/high dose-rate brachytherapy, radioisotope, and particle therapy.

Transparency of NCCN Guidelines and Compendia development is central to the philosophy, policies, and procedures of NCCN. NCCN posts the policies and processes for developing and maintaining the NCCN Guidelines. These policies are available to the public on the NCCN website. Identification of newly published research, NCCN Member Institution review, external stakeholder submissions, and panel review occur on an ongoing basis with at least annual review performed for NCCN Guidelines for each disease.

The NCCN Radiation Therapy Compendium™ includes radiation therapy recommendations for the following 24 cancer types:

Acute myeloid leukemia Anal cancer B-cell lymphomas Bladder cancer Breast cancer Chronic lymphocytic leukemia/ small lymphoblastic lymphoma Colon cancer Hepatobiliary cancers Kidney cancer Malignant pleural mesothelioma Melanoma Multiple myeloma Neuroendocrine tumors Non–small cell lung cancer Occult primary Pancreatic adenocarcinoma Penile cancer Primary cutaneous B-cell lymphomas Prostate cancer Rectal cancer Small cell lung cancer Soft-tissue sarcoma T-cell lymphomas Testicular cancer

Additional cancer types will be published on a rolling basis over the coming months.

For more information and to access the NCCN Radiation Therapy Compendium™, visit NCCN.org/RTCompendium.